Medical Fluid Bags Market size was valued at USD 3.8 Bn. in 2021 and the total Medical Fluid Bags Market revenue is expected to grow at 6.8 % from 2022 to 2029, reaching nearly USD 6.43 Bn.Medical Fluid Bags Market Overview:
Medical fluid bags are used in fluid replacement therapy to prevent electrolyte imbalances, blood transfusions, and improper bodily fluid collection, as well as to ensure oral or enteral patient nutrition. These bags primarily consist of various polymers and have compartments for holding bodily fluids for various biomedical operations. Medical fluid bags come in a range of sizes and are made of an interior pouch and an outer plastic coating. The fluids are protected by the compartmentalization of these bags into an inner pouch and an outside coating up until the proposed expiration date written on the bags. These bags are frequently employed in healthcare settings with a multipurpose approach to maintain adequate sterilized conditions for the blood samples that help in assuring infection-free premises, slowing the transmission of disease, and preventing any loss of blood samples or medications. Additionally, these bags are employed in fluid replacement therapy, which is carried out to guarantee proper body fluid collection, blood transfusions, electrolyte imbalances, and maintenance of the patient's healthy nutritional intake via an oral or enteral route of administration.Research Methodology:
In order to evaluate and forecast the Medical Fluid Bag Market, MMR first collected information on the revenues of the major global players and local players. Vendors' products are evaluated using the following parameters to segment the market: by Product Type(Blood Bags, Intravenous Bags, Drain Bags, Dialysis Bags, Others) Material (PVC Compounds, Polyolefins, Others) End user (Hospitals, Blood Banks, Others) Later, in order to corroborate these divisions through primary research, in-depth interviews with prominent individuals, including market experts, key opinion leaders, purchase officers, and managers, were undertaken. Market size is determined by using the bottom-up technique. To determine the key market players in the medical fluid bag sector and to estimate their market revenues, primary and secondary research is conducted. Instead of only depending upon secondary research, a primary research technique was employed, entailing reading the annual and financial reports of the major manufacturers and consulting with well-known opinion and business leaders in the sector, key opinion leaders, and purchase officers.To know about the Research Methodology :- Request Free Sample Report
Report scope:
The goal of the study is to give market participants a detailed understanding of the Medical Fluid Bag Market. In the study, the market's recent ongoing, and estimated future developments are examined. It also offers an easy analysis of complicated data. One of the main factors that actively and thoroughly conduct research is new entrants, market leaders, and followers. The research shows the outputs of the PORTER and PESTEL assessments in addition to potential outcomes of the microeconomic market components. Decision-makers will have a clear futuristic perspective of the market after taking into account internal and external factors that could have a positive or negative impact on the organization. Investors can better grasp the dynamics and structure of the medical fluid bag market thanks to the market segmentation analysis and market size forecast in the study. By clearly laying out the comparative study of the top medical fluid bag enterprises by price, financial status, product, product portfolio, growth strategies, and regional presence, the research serves as a buyer's guideMedical Fluid Bags Market Dynamics:
Market Drivers: One of the main factors boosting the growth of the medical fluid bags market globally is the increase in the prevalence of various chronic diseases including diabetes, cancer, cardiovascular diseases, and renal, and liver infections. Additionally, the business will develop as gastrointestinal diseases become more common, especially among the senior population. The usage of PVC-based medical fluid bags can have negative health effects on patients, and improper disposal might have a negative environmental impact. These issues could slow the market's expansion. On the other hand, the usage of intravenous fluid bags has increased dramatically due to the global expansion of hospitals and the healthcare industry. The use of blood bags is expected to increase as more governmental and private groups launch campaigns to encourage blood donations. The market for medical fluid bags' blood bags sector had sales of USD 343.5 million in 2021, driven by an increase in blood donations and attempts by public and private organizations to encourage blood donations globally. For instance, the Chinese government accepted the idea of voluntary, unpaid donation, put in place several regulations for effective blood transfusion, and included cutting-edge blood testing technologies to guarantee an adequate supply of blood. Between 1998 and 2018, China saw a 275.1 % increase in blood donors (from 4 million to 15 million). Similar to this, Facebook introduced its Blood Donations option in several nations, including South Africa, Senegal, Egypt, the United States, India, and Brazil. This characteristic supported the growth of the medical fluid bag market by assisting blood donation facilities in Brazil and India. According to surveys, this Facebook push encouraged 20% of people to donate blood. In blood centers, blood bags are frequently used for blood collection, sorting, storage, and transportation. Market Restraints: Concerns about incorrect disposal harming the environment and health issues related to the use of PVC-based medical fluid bags on patients hamper the market growth. The National Centers for Biotechnology Information (NCBI) asserts that extended exposure to endocrine disruptors including di-(2-Ethylhexyl) phthalate (DEHP) and bisphenol-A (BPA) is linked to major health problems. Market Opportunities: Medical admissions are increasing throughout the world. Chronic diseases, incidences of accidents brought on by human error or natural disasters, and kidney-related issues requiring routine dialysis are all on the rise. In recent years, the number of people needing blood transfusions has also increased significantly. These factors likely fuel the growth of the global market. Disposable IV bags are increasingly being used by end-users in hospitals to prevent hospital-acquired illnesses and lower overall healthcare costs. Given the practicality and affordability of disposable IV bags, which are used in blood transfusion to avoid numerous blood-borne illnesses, a similar trend has been noticed in blood banks. The future expansion of the global market for medical fluid bags is expected to benefit from this shift in preference. To satisfy the increasing demand, major market players are putting a lot of effort into developing newer and better medical fluid bags. One example is the production of PVC-free bags that are constructed of non-latex materials and may be used for frozen, customized, or cold medicinal components. Along with government and private sector initiatives, there is a rise in blood donation activities all over the world. This is made possible by increasing public knowledge of the advantages of blood donation. Given the enormous attention the global market is receiving, significant revenue growth is expected throughout the forecast period. They are concentrating on providing marble floor tiles to merchants in the UAE for use in residential and commercial applications.Medical Fluid Bags Market Segment Analysis:
Based on Product Type, The Blood Bags segment is expected to grow at the highest CAGR during the forecast period. Owing to the growth in patients with various illnesses connected to blood, kidney, metabolic, and neurological issues, blood bags are in high demand. Cancers that affect the bone marrow, blood cells, lymph nodes, and other components of the lymphatic system include leukemia, lymphoma, myeloma, and myelodysplastic syndromes (MDS). Apheresis technology has been seen to be utilized to lower the number of white cells until other drugs can manage them. For instance, the Leukemia and Lymphoma Society (LLS) Factsheet estimates that in August 2021, one person in the United States will receive a blood cancer diagnosis every three minutes. Additionally, according to the same source, 186,405 Americans will receive leukemia and lymphoma diagnoses in 2021. Additionally, 672,985 people and 825,655 people in the US had non-Hodgkin lymphoma and 152,671 people had Hodgkin lymphoma, respectively. Thus, the increase in blood cancer instances is contributing to the target market's growth.Based on Material, The PVC Compounds segment is expected to grow at the highest CAGR during the forecast period. The PVC medical bags are inexpensive when compared to other options, easy to handle, and steam sterilizable. These bags are highly favored for the collection and storage of blood and blood components since they guarantee a shelf life of 42 days, which is essential for the preservation of uncommon blood types. PVC blood bags allow for the highest levels of sterilization and, if necessary, freezing. Furthermore, two of the PVCMed Alliance's member businesses have created phthalate- and DEHP-free PVC blood bags that satisfy the strict specifications for blood collection and storage. The adoption rate of PVC medical bags will rise as DEHP-free alternatives are developed. Based on End User, The Hospitals segment is expected to grow at the highest CAGR during the forecast period. Owing to the rising rates of hospitalizations and diarrheal illnesses. According to the PLOS Neglected Tropical Diseases, estimations show that between 66,401 and 249,010 children are expected to be hospitalized each year in India and that between 5,805 and 14,605 deaths are reported to be related to diarrhea. The WHO estimates that 1.7 billion children under the age of five have diarrheal illnesses, which causes 525,000 child fatalities per year. The figure is substantially greater in emerging nations, particularly in those of Africa and South Asia.
Increasing hospital visits and an increase in surgery volume across the continent will propel North America to dominate the medical fluid bag market, which will reach 1.16 billion by 2029.Statistics from the Healthcare Cost and Utilization Project show that at hospitals and ambulatory surgery centers for invasive and therapeutic procedures, there were about 17.2 million hospital visits reported nationwide. Inpatient surgeries totaled almost 48 million in the United States, according to data from the National Center for Health Statistics. As medical fluid bags are a necessary component of surgical supplies and are used to drain physiological fluids from patients as well as provide liquid drugs, nutrients, electrolytes, and blood, the rise in surgical procedures is expected to be advantageous for the industry. The majority of Europe's medical fluid bags were sold in Germany, which is expected to surpass USD 265.5 million in sales by 2029 as a result of the country's aging population and increased rates of chronic illnesses. The Globocan (Global Cancer Observatory) estimates that 628,520 persons in the nation will receive a cancer diagnosis in 2021, and that number will likely to grow during the forecast period. About 5 to 6.5 million people in Germany experience kidney dysfunction, according to the German Kidney Foundation. While in the nation, about 80,000 individuals are presently receiving long-term dialysis care. According to the Robert Koch Institute, 1 in every 8 people between the ages of 70 and 79 have chronic renal disease. The use of medical fluid bags in healthcare settings is anticipated to increase because of the high percentage of the population suffering from cancer and chronic kidney diseases, as well as the growing elderly population.
Medical Fluid Bags Market Regional Insights:
Medical Fluid Bags Market Scope: Inquire before buying
Medical Fluid Bags Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 3.8 Bn. Forecast Period 2022 to 2029 CAGR: 6.8% Market Size in 2029: US $ 6.43 Bn. Segments Covered: by Product Type • White • Black • Yellow • Red • Others by Material • PVC Compounds • Polyolefins • Others by End-user • Hospitals • Blood Banks • Others Medical Fluid Bags Market, by Region
• North America • Europe • Asia Pacific • Middle East and Africa • South AmericaGlobal Top Manufacturers in Medical Fluid Bags Market are:
• B. Braun (Germany) • Fresenius Kabi (Germany) • Pfizer Inc. (US) • Kawasumi Laboratories (Japan) • KRATON CORPORATION (US) • Macopharma Pvt ltd (India) • Pall Corporation (US) • Westfield Medical (UK) • Amsino International, Inc (US) • Coloplast (Denmark) • RENOLIT SE (Germany) • C.R.Bard (BD) (US) • Sippex (France) • Smiths Medical (US) • Technoflex SA (France) • Wipak (Finland) • Vonco Products, LLC. (US) • Baxter International (US) • Terumo Corporation (Japan) • Thermo Fisher Scientific (US) • Serres Oy (Finland) • Sealed Air (US) • POLYCINE GmbH (Germany) • Dow (US) • Amcor (Australia) FAQs: 1. Which is the potential market for the Medical Fluid Bags Market in terms of the region? Ans. In North America region, the growing business and educational sectors are expected to help drive the use of collaborative screens. 2. What are the opportunities for new market entrants? Ans. The key opportunity in the market is new initiatives from governments that provide funding for Medical Fluid Bags Markets in educational institutes 3. What is expected to drive the growth of the Medical Fluid Bags Market in the forecast period? Ans. A major driver in the Medical Fluid Bags Market is the prevalence of work from home and remote collaboration created by the COVID-19 pandemic 4. What is the projected market size & growth rate of the Medical Fluid Bags Market? Ans. The Medical Fluid Bags Market size was valued at US$ 3.8 Billion in 2021 and the total Medical Fluid Bags Market revenue is expected to grow at 6.8 % through 2021 to 2029, reaching nearly US$ 6.43 Billion. 5. What segments are covered in the Medical Fluid Bags Market report? Ans. The segments covered are Product Type, Material, End user and, Region.
1. Global Medical Fluid Bags Market Size: Research Methodology 2. Global Medical Fluid Bags Market Size: Executive Summary 2.1. Market Overview and Definitions 2.1.1. Introduction to Global Medical Fluid Bags Market Size 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Medical Fluid Bags Market Size: Competitive Analysis 3.1. MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2. Consolidation in the Market 3.2.1 M&A by region 3.3. Key Developments by Companies 3.4. Market Drivers 3.5. Market Restraints 3.6. Market Opportunities 3.7. Market Challenges 3.8. Market Dynamics 3.9. PORTERS Five Forces Analysis 3.10. PESTLE 3.11. Regulatory Landscape by region • North America • Europe • Asia Pacific • Middle East and Africa • South America 3.12. COVID-19 Impact 4. Global Medical Fluid Bags Market Size Segmentation 4.1. Global Medical Fluid Bags Market Size, by Product Type (2021-2029) • Blood Bags • Intravenous Bags • Drain Bags • Dialysis Bags • Others 4.2. Global Medical Fluid Bags Market Size, by Material (2021-2029) • PVC Compounds • Polyolefins • Others 4.3. Global Medical Fluid Bags Market Size, by End user (2021-2029) • Hospitals • Blood Banks • Others 5. North America Medical Fluid Bags Market (2021-2029) 5.1. North America Medical Fluid Bags Market Size, by Product Type (2021-2029) • Blood Bags • Intravenous Bags • Drain Bags • Dialysis Bags • Others 5.2. North America Medical Fluid Bags Market Size, by Material (2021-2029) • PVC Compounds • Polyolefins • Others 5.3. North America Medical Fluid Bags Market Size, by End-user (2021-2029) • Hospitals • Blood Banks • Others 5.4. North America Medical Fluid Bags Market, by Country (2021-2029) • United States • Canada • Mexico 6. European Medical Fluid Bags Market (2021-2029) 6.1. European Medical Fluid Bags Market, by Product Type (2021-2029) 6.2. European Medical Fluid Bags Market, by Material (2021-2029) 6.3. European Medical Fluid Bags Market, by End user (2021-2029) 6.4. European Medical Fluid Bags Market, by Country (2021-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Medical Fluid Bags Market (2021-2029) 7.1. Asia Pacific Medical Fluid Bags Market, by Product Type (2021-2029) 7.2. Asia Pacific Medical Fluid Bags Market, by Material (2021-2029) 7.3. Asia Pacific Medical Fluid Bags Market, by End user (2021-2029) 7.4. Asia Pacific Medical Fluid Bags Market, by Country (2021-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Medical Fluid Bags Market (2021-2029) 8.1. Middle East and Africa Medical Fluid Bags Market, by Product Type (2021-2029) 8.2. Middle East and Africa Medical Fluid Bags Market, by Material (2021-2029) 8.3. Middle East and Africa Medical Fluid Bags Market, by End user (2021-2029) 8.4. Middle East and Africa Medical Fluid Bags Market, by Country (2021-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Medical Fluid Bags Market (2021-2029) 9.1. South America Medical Fluid Bags Market, by Product Type (2021-2029) 9.2. South America Medical Fluid Bags Market, by Material (2021-2029) 9.3. South America Medical Fluid Bags Market, by End user (2021-2029) 9.4. South America Medical Fluid Bags Market, by Country (2021-2029) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1. B. Braun (Germany) 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Fresenius Kabi (Germany) 10.3. Pfizer Inc. (US) 10.4. Kawasumi Laboratories (Japan) 10.5. KRATON CORPORATION (US) 10.6. Macopharma Pvt ltd (India) 10.7. Pall Corporation (US) 10.8. Westfield Medical (UK) 10.9. Amsino International, Inc (US) 10.10. Coloplast (Denmark) 10.11. RENOLIT SE (Germany) 10.12. C.R.Bard (BD) (US) 10.13. Sippex (France) 10.14. Smiths Medical (US) 10.15. Technoflex SA (France) 10.16. Wipak (Finland) 10.17. Vonco Products, LLC. (US) 10.18. Baxter International (US) 10.19. Terumo Corporation (Japan) 10.20. Thermo Fisher Scientific (US) 10.21. Serres Oy (Finland) 10.22. Sealed Air (US) 10.23. POLYCINE GmbH (Germany) 10.24. Dow (US) 10.25. Amcor (Australia)